專業人才

蕭長春 ,Ph.D.
單位: 長庚大學 / 高雄長庚
現職: 臨床醫學研究所 副教授 / 基因體暨蛋白質體核心實驗室 顧問
聯絡地址: 高雄市鳥松區大埤路123號
電話: 07-7317123 轉 8856 傳真: 07-7311696
E-mail: cchsiao@mail.cgu.edu.tw

研究領域:
  • 組織工程
  • 幹細胞
  • 癌症
  • 震波醫學


學歷:
  》美國明尼蘇達大學 生物醫學工程 博士

代表論文:
  1. Yung-Che Chen, Chang-Chun Hsiao*, Chung-Jen Chen, Tung-Ying Chao, Sum-Yee Leung, Shih-Feng Liu, Chin-Chou Wang, Ting-Ya Wang, Jen-Chieh Chang, Chao-Chien Wu, An-Shen Lin, Yi-Hsi Wang, Meng-Chih Lin.  Aberrant Toll-like receptor 2 promoter methylation in blood cells from patients with pulmonary tuberculosis. Journal of Infection, http://dx.doi.org/10.1016/j.jinf.2014.08.014, 1-12, 2014.
  2. Shu-Fang Jian#, Chang-Chun Hsiao#, Shin-Yi Chen, Ching-Chieh Weng, Tzu Lei Kuo,Deng-Chyang Wu, Wen-Chun Hung, and Kuang- Hung Cheng. Utilization of Liquid Chromatography Mass Spectrometry Analyses to Identify LKB1-APC Interaction in Modulating Wnt/β-Catenin Pathway of Lung Cancer Cells. Molecular Cancer Research, 12(4):622-35, 2014.  #S.-F. Jian and C.-C. Hsiao contributed equally to this work, first author.
  3. Yi-Hao Yen, Jyh-Chwan Wang, Chao-Hung Hung, Sheng-Nan Lu,Jing-Houng Wang, Tsung-Hui Hu, Kwong-Ming Kee,Chang-Chun Hsiao*, Chuan-Mo Lee. Serum proteome predicts virological response in chronic hepatitis C genotype 1b patients treated with pegylated interferon plus ribavirin. Journal of the Formosan Medical Association, http://dx.doi.org/10.1016/j.jfma.2013.04.013, 2013.
  4. Cheng-I Cheng, Chang-Chun Hsiao, Shinn-Chih Wu, Shao-Yu Peng, Hon-Kan Yip,Morgan Fu, Feng-Sheng Wang. Valsartan Impairs Angiogenesis of Mesenchymal Stem Cells through Akt Pathway. International Journal of Cardiology, 167: 2765-2774, 2013.
  5. Yung-Che Chen, Chang-Chun Hsiao, Kuang-Den Chen, Yu-Chiang Hung, Ching-Yuan Wu, Chien-Hao Lie, Shih-Feng Liu, Ming-Tse Sung, Chung-Jen Chen, Ting-Ya Wang, Jen-Chieh Chang, Petrus Tang, Wen-Feng Fang, Yi-Hsi Wang, Yu-Hsiu Chung, Tung-Ying Chao, Sum-Yee Leung, Mao-Chang Su, Chin-Chou Wang, Meng-Chih Lin. Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy. PLoS ONE, 8(2): e57053, 1-16, 2013


所有論文著作一覽表

學會與認證:
  》Member of the Tissue Engineering and Regenerative Medicine International Society
  》Member of the International Society for Stem Cell Research
  》Member of the American Chemical Society
  》Member of the Human Proteome Organisation
  》Member of the Taiwan Institute of Chemical Engineering
  》中華生化工程學會永久個人會員
  》台灣蛋白體學會會員
  》臺灣幹細胞學會會員